PharmiWeb.com - Global Pharma News & Resources
15-Mar-2023

SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO

SYNLAB AG / Key word(s): Personnel
SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO

15-March-2023 / 18:05 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO

Munich, 15 March 2023 – The Supervisory Board of SYNLAB AG (SYNLAB, FSE: SYAB) today announces that the appointment of Mathieu Floreani as Chief Executive Officer (CEO) of the SYNLAB Group has been extended until the end of 30 April 2028 and the appointment of Sami Badarani as Chief Financial Officer (CFO) of the SYNLAB Group has been extended until the end of 30 April 2026.
 

15-March-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: SYNLAB AG
Moosacher Straße 88
80809 Munich
Germany
Phone: +49 1701183753
E-mail: ir@synlab.com
Internet: www.synlab.com/
ISIN: DE000A2TSL71
WKN: A2TSL7
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1583627

 
End of Announcement EQS News Service

Editor Details

Last Updated: 15-Mar-2023